Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease

Patients with lung disease caused by Mycobacterium abscessus subsp. abscessus (here M. abscessus) typically have poor treatment outcomes. Although clofazimine (CFZ) has been increasingly used in the treatment of M. abscessus lung disease in clinical practice, there are no reported data on its effect...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Yang, Bumhee, Jhun, Byung Woo, Moon, Seong Mi, Lee, Hyun, Park, Hye Yun, Jeon, Kyeongman, Kim, Dae Hun, Kim, Su-Young, Shin, Sung Jae, Daley, Charles L., Koh, Won-Jung
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2017
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444135/
https://ncbi.nlm.nih.gov/pubmed/28348153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02052-16
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires